Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
734.97 | -46,29% | -24,25% | 661.770,95 | 0,71% | 2,63% |
|
NYSE:ABBV
AbbVie
|
163.79 | -21,82% | -11,49% | 290.014,27 | 3,79% | 7,03% |
|
LSE:AZN
AstraZeneca PLC
|
120.50 | 19,51% | 42,34% | 186.803,32 | 2,05% | 15,98% |
|
NYSE:PFE
Pfizer
|
27.81 | 11,74% | 42,95% | 157.475,27 | 6,04% | -9,31% |
|
NYSE:TEVA
Teva Pharmaceutical Industries
|
13.98 | -37,32% | -33,28% | 15.834,32 | 0% | -2,6% |
|
NasdaqGS:VTRS
Viatris Inc
|
11.78 | 1,95% | 12,16% | 13.740,18 | 4,07% | -8,55% |
|
CPSE:HLUN A
H. Lundbeck A/S
|
33.50 | 96,51% | 123,29% | 32.856,1 | 2,09% | 32,92% |
|
NasdaqGS:ALKS
Alkermes
|
24.05 | 175,95% | 200,99% | 4.062,11 | 0% | 18,74% |
|
LSE:INDV
Indivior PLC
|
14.35 | -23,61% | -1,68% | 1.952,43 | 0% | -2,7% |
|
NasdaqGM:VNDA
Vanda Pharmaceuticals
|
4.88 | 0% | 0% | 284,01 | 0% | -8,62% |
